期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 118, 期 4, 页码 1255-1265出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI34614
关键词
-
资金
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000734] Funding Source: NIH RePORTER
- Intramural NIH HHS [Z01 AI000783-11] Funding Source: Medline
- Medical Research Council [MC_U117581288] Funding Source: Medline
- MRC [MC_U117581288] Funding Source: UKRI
Tuberculosis (TB) is a major threat to global health, recently exacerbated by the emergence of highly drug-resistant forms of the disease-causing pathogen and synergy with HIV/AIDS. In 2006, the Stop TB Partnership published The global plan to stop TB: 2006-2015, which set out a vision of halving the prevalence of and mortality caused by the disease by 2015, followed by eliminating the disease as a public health problem by 2050. This vision depends on the development of improved diagnostics, simpler treatment, and more effective vaccination. Recently; active translational research pipelines directed toward each of these goals have been established, but improved understanding of the fundamental biology of this complex disease will prove to be the key to radical advances in TB control.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据